SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > SQI Q2 results.

<< Previous

Bullboard Posts

Next >>

Post by 25Stone7859on May 11, 2022 2:30pm

144 Views

Post# 34674865

SQI Q2 results.

To be released May 25th. Not sure if any data on the AZOVA launch will be provided. Recall that January/2022 unaudited revenue from PBI was stellar but not a peep since. So is this a classic case of no news is not such good news ?

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”